Home › Funds › Euclidean Capital LLC › SRZN

Euclidean Capital LLC position in SRZN

SURROZEN INC · Health Care

Euclidean Capital LLC reported holding 87,696 shares of SRZN (SURROZEN INC) in its Q2 2026 13F filing — a position valued at US$2.3M, representing 0.52% of its reported portfolio and ranking #9 among its reported holdings. Euclidean Capital LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)87.70K sh
Reported value held$2.28M
Portfolio Weight0.52%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Euclidean Capital LLC's SRZN position evolved

Euclidean Capital LLC first disclosed a stake in SRZN in Q3 2023 at 1,315,463 shares (US$645K). The position peaked in Q1 2026 at 87,696 shares, worth US$2.6M. Across 12 filings, Euclidean Capital LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 10 time(s). The most recent filing (Q2 2026) shows 87,696 shares valued at US$2.3M. Notable position changes include a 93% trim in Q4 2023 (shares rose 67% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.32M $644.58K New
Q4 2023 87.70K $824.34K Reduce
Q1 2024 87.70K $1.38M Hold
Q2 2024 87.70K $960.27K Hold
Q3 2024 87.70K $1.05M Hold
Q4 2024 87.70K $1.26M Hold
Q1 2025 87.70K $1.02M Hold
Q2 2025 87.70K $784.00K Hold
Q3 2025 87.70K $1.13M Hold
Q4 2025 87.70K $1.98M Hold
Q1 2026 87.70K $2.55M Hold
Q2 2026 87.70K $2.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SRZN and 13F data

SRZN (SURROZEN INC) is a Health Care company. 51 other funds we track also report a position in SRZN — the largest reported positions include Column Group LLC (US$49.7M), TCG Crossover Management, LLC (US$38.2M), Boxer Capital Management, LLC (US$27.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRZN

All SRZN fund holders →

FAQ

How long has Euclidean Capital LLC held SRZN?

Euclidean Capital LLC has disclosed SRZN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Euclidean Capital LLC's current position in SRZN?

As of Q2 2026, Euclidean Capital LLC holds 87.70K shares of SRZN (SURROZEN INC), valued at $2.28M, representing 0.52% of its reported portfolio and ranking #9.

Has Euclidean Capital LLC been buying or selling SRZN?

In the latest 13F filing (Q2 2026), Euclidean Capital LLC held unchanged its position in SRZN. The position peaked in Q1 2026 at 87.70K shares.

Which other funds hold SRZN?

Other major institutional holders of SRZN include Column Group LLC, TCG Crossover Management, LLC, Boxer Capital Management, LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.